|
|
 |
 |
|
Kirsten L. Greene, MD, MS
Recent Publications |
Publications – 2008 |
 |
Breyer, B.N., K.L.
Greene, M.A. Dall'Era,
B.J. Davies, and C.J. Kane, Pelvic lymphadenectomy in prostate
cancer. Prostate Cancer Prostatic Dis, 2008. 11(4): p. 320-4. |
|
| |
Publications – 2007 |
|
Garcia, M.M., S. Gulati, D. Liepmann, G.B.
Stackhouse, K. Greene, and M.L. Stoller, Traditional Foley
drainage systems--do they drain the bladder? J Urol, 2007.
177(1): p. 203-7; discussion 207. |
|
Greene, K.L., Does finasteride increase
PSA sensitivity? Abstr Hematol Oncol, 2007. 10(1): p. commentary. |
|
Greene, K.L., Prostate cancer: the problems
of overdiagnosis and overtreatment. Abstr Hematol Oncol,
2007. 10(1): p. commentary. |
|
| |
Publications – 2006 |
|
Greene, K.L., A. Berry, and B.R. Konety, Diagnostic
Utility of the ImmunoCyt/uCyt+ Test in Bladder Cancer. Rev Urol, 2006.
8(4): p. 190-7. |
|
Greene, K.L., E.P. Elkin, A. Karapetian,
J. Duchane, P.R. Carroll, and C.J. Kane, Prostate biopsy
tumor extent but not location predicts recurrence after
radical prostatectomy: results from CaPSURE. J Urol,
2006. 175(1): p. 125-9; discussion 129. |
|
Pookot, D., L.C. Li, Z.L. Tabatabai,
Y. Tanaka, K.L. Greene, and R. Dahiya, The E-cadherin
-160 C/A polymorphism and prostate cancer risk in white
and black American men. J Urol, 2006. 176(2): p. 793-6.
|
| |
return
to top
|
|
|
|
|
|
|
